Work

Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK

Year: 2022

Type: article

Study design: Observational Study

Source: The Lancet

DOI: 10.1016/s0140-6736(22)01349-6

Authors: Nathalie Conrad, Geert Verbeke, Geert Molenberghs, Laura Goetschalckx, Thomas Callender, Geraldine Cambridge, Justin C Mason, Kazem Rahimi, John J V McMurray, Jan Y Verbakel

Institutions: KU Leuven, Hasselt University, University College London, Imperial College London, University of Oxford, University of Glasgow

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Wellcome Trust, UK Research and Innovation, National Institute for Health and Care Research, British Heart Foundation, European Commission, European Society of Cardiology, Oxford Health NHS Foundation Trust, Economic and Social Research Council

Awards: G1256548025, Research Excellence (round 3), The effect of blood pressure lowering drugs and drug-drug interactions on the risk of type 2 diabetes: integrating epidemiologic and genetic data, Investigating the stratified efficacy and safety of pharmacological blood pressure lowering: individual patient-level data meta-analyses of over 300,000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration, G4292647728, G4474749, G5261545915, G6685406930, GCRF: Building capacity for the future city in developing countries (PEAK), Chronic inflammation and cardiovascular risk, G7663417832

OpenAlex ID: W4293331178

FWCI: 54.47

Cites: 33

Cited by: 481

Related to: 10